{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4.03 vs. cons ~$3.96",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$13.65B vs. cons ~$13.5B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Aerospace segment operating margin",
      "prediction": "MISS",
      "answer": "pred ~14.6% vs. cons ~15.0%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$16.45-$16.55 vs. cons ~$16.50 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Free cash flow cadence/conversion",
      "prediction": "UNCHANGED",
      "answer": "guide ~positive FCF each remaining quarter, ~$3.3-3.5B FY vs. cons ~$3.4B (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Aerospace order/backlog commentary (Middle East demand)",
      "prediction": "UNKNOWN",
      "answer": "guide ~qualitative stabilization vs. cons expecting continued softness (Q2 2026 / FY2026 outlook)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.3,
  "day5_path": "FADE",
  "day5_rationale": "Stock has run +16% in two months into the print (24x trailing EPS, near all-time highs) on the back of a Q1 beat and mid-year guide raise, so a merely solid Q2 (flagged by management itself as a flattish, mix-heavy 'digestion' quarter) is unlikely to justify further multiple expansion; without a second consecutive guidance raise, sell-side will likely leave FY26 numbers roughly intact while trimming near-term Aerospace order assumptions given Middle East disruption, producing a 'beat-but-sell-the-news' day-1 dip that extends modestly over the week as investors rotate out of the crowded, highly-valued defense trade rather than add on an in-line-to-modest-beat result.",
  "day5_confidence": "MEDIUM"
}